Geron Market Cap

Geron has a market cap or net worth of $2.73 billion as of July 22, 2024. Its market cap has increased by 70.79% in one year.

Market Cap

2.73B

Enterprise Value

2.37B

1-Year Change

70.79%

Ranking

#1713

Market Cap Chart

Since December 1, 1998, Geron's market cap has increased from $159.40M to $2.73B, an increase of 1,611.68%. That is a compound annual growth rate of 11.71%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	2.73B	138.10%
Dec 29, 2023	1.15B	24.20%
Dec 30, 2022	922.60M	134.88%
Dec 31, 2021	392.80M	-20.44%
Dec 31, 2020	493.70M	81.71%
Dec 31, 2019	271.70M	45.84%
Dec 31, 2018	186.30M	-35.00%
Dec 29, 2017	286.60M	-12.99%
Dec 30, 2016	329.40M	-56.99%
Dec 31, 2015	765.80M	49.89%
Dec 31, 2014	510.90M	-16.42%
Dec 31, 2013	611.30M	231.51%
Dec 31, 2012	184.40M	-5.24%
Dec 30, 2011	194.60M	-63.43%
Dec 31, 2010	532.20M	4.66%
Dec 31, 2009	508.50M	37.54%
Dec 31, 2008	369.70M	-13.62%
Dec 31, 2007	428.00M	-26.52%
Dec 29, 2006	582.50M	4.37%
Dec 30, 2005	558.10M	53.45%
Dec 31, 2004	363.70M	-6.72%
Dec 31, 2003	389.90M	337.60%
Dec 31, 2002	89.10M	-53.52%
Dec 31, 2001	191.70M	-42.86%
Dec 29, 2000	335.50M	58.25%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MorphoSys AG	2.82B
MoonLake Immunotherapeutics	2.81B
SpringWorks Therapeutics	2.79B
Bausch Health Companies	2.79B
Apogee Therapeutics	2.78B
Agios Pharmaceuticals	2.65B
Progyny	2.65B
Kymera Therapeutics	2.64B

Market Cap Rankings